Advos

Regentis Biomaterials is nearing U.S. FDA approval for its off-the-shelf GelrinC hydrogel implant, targeting a market of 472,500 annual knee cartilage procedures lacking a regenerative solution.

Planet Ventures Inc. is leveraging a portfolio-driven investment strategy to provide exposure to high-growth private space companies, aiming to create shareholder value as the global space industry expands.

Aegis Capital Corp. facilitated a secondary sale of approximately $15 million in equity of Perplexity AI, highlighting continued investor interest in AI-powered search engines.

Regentis Biomaterials' cell-free hydrogel implant GelrinC aims to simplify knee cartilage repair, targeting a $3 billion U.S. market with promising clinical outcomes and nearing pivotal U.S. trial completion.

Flexible workspace operators are underestimating meeting room demand due to hybrid work patterns, leading to lost revenue and member frustration, with data from Vallist's Holborn location revealing the need for larger meeting rooms.

Congressman Jimmy Patronis highlights permitting delays and soft costs as the most urgent policy issue for construction, while discussing infrastructure funding and workforce shortages on the Beyond the Build podcast.

The Multiple Listing Service is at a crossroads due to the NAR settlement and brokerage consolidation, yet most agents have not recognized the urgency, according to Colorado Realtor leader Mark Gordon.

A wave of commercial real estate loans originated during low-rate years is maturing, forcing investors to choose between paying off, refinancing at higher rates, or selling into a buyer's market.

The International Energy Agency forecasts global electric vehicle sales will hit 23 million units in 2026, accounting for nearly 30% of car sales worldwide, with China and Europe leading adoption.

The surging demand for AI chips has driven Micron and SK Hynix's market capitalizations above $1 trillion, highlighting the semiconductor industry's central role in the AI revolution.

A global survey by Northern Trust reveals that major institutional investors, including pension funds, are slowly entering the cryptocurrency market with caution, which could impact trading volumes on exchanges like Coinbase.

In 2025, renewable energy sources generated more electricity than coal globally, marking a historic milestone in the shift toward cleaner energy.

Progress in US-Iran negotiations, including a potential reopening of the Strait of Hormuz and ceasefire, is improving sentiment in commodity markets, strengthening the near-term outlook for copper amid a supply-side crunch.

Pope Leo XIV cautions that rapid AI advancement could undermine employment, social fairness, and human worth, while firms like Datavault AI Inc. continue to leverage AI for beneficial purposes.

The US CDC has broadened its travel ban to include green card holders who have been to Uganda, South Sudan, and the DRC within the past 21 days, raising concerns among healthcare stakeholders about potential Ebola importation.

Cryptocurrency markets edged higher as betting markets indicate increased chances of a near-term US-Iran deal, with implications for crypto firms and market stability.

Nevada Organic Phosphate Inc. has announced promising initial observations from its 2026 exploration program at the Murdock Mountain Property, intersecting approximately 39 metres of the targeted phosphate interval amid growing concerns over domestic phosphate supply and global supply-chain risks.

Rail Vision Ltd. has signed a non-binding MOU with Railserve Inc. to explore expanding their AI-powered rail yard collaboration, potentially advancing semi-autonomous operations.

ParaZero Technologies Ltd. has engaged a subcontractor to scale production of its DefendAir net pod systems, aiming to produce thousands of units annually to meet growing global demand for counter-UAS solutions.

Redwood AI Corp. has signed a non-binding letter of intent to acquire Quantum.IQ, an AI-driven quantum cybersecurity company, aiming to bolster its capabilities in cryptographic intelligence and quantum-readiness assessment.

New data presented by Tonix Pharmaceuticals reveals that despite guidelines discouraging opioid use, nearly 40% of fibromyalgia patients are prescribed opioids, highlighting a gap in care and the need for non-opioid treatments like TONMYA.